Orforglupron

1 statements across 1 episodes · 1 bullish · 0 bearish · 1 people on the record · first statement Oct 8, 2024 by Dave Ricks · across every show →

Everything said about Orforglupron, oldest first

Oct 8, 2024 bullish
Assertion Supported
Eli Lilly oral GLP-1 shows efficacy matching high-dose semaglutide in trials
“In our hands, it, it's about as good as high dose semaglutide, and we, we're doing phase three right now. So that will start to read out next year.”
Dave Ricks Oct 8, 2024 ▶ 36:44 Dave Ricks, CEO of Eli Lilly | The All-In Interview
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 460 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.